Position in SNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$613,962
-$386,977 QoQ
Shares Held
14,392
-30.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#305
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Voya Financial Advisors, Inc. holds $8,834,039 across 10 Drug Manufacturers - General names. SNY ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
31,519 | $1,652,225 | |
| 2 | NVS |
Novartis AG
|
10,020 | $1,570,334 | |
| 3 | AMGN |
Amgen Inc
|
3,137 | $1,135,970 | |
| 4 | LLY |
ELI LILLY & Co
|
805 | $965,541 | |
| 5 | ABBV |
AbbVie Inc.
|
3,390 | $853,059 | |
| 6 | PFE |
Pfizer Inc
|
34,853 | $839,260 | |
| 7 | SNY |
Sanofi
This page
|
14,392 | $613,962 | |
| 8 | JNJ |
Johnson & Johnson
|
1,866 | $473,908 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $613,962 | 14,392 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,000,939 | 20,775 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,034,184 | 21,341 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,001,725 | 21,223 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $1,016,973 | 21,051 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,148,188 | 20,703 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $968,313 | 20,077 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,126,205 | 19,542 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $931,681 | 19,202 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $844,327 | 17,373 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $697,960 | 14,035 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $727,787 | 13,568 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $521,590 | 9,677 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $490,052 | 9,005 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $411,800 | 8,503 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $400,844 | 10,543 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $506,303 | 10,120 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $458,722 | 8,935 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $348,896 | 6,964 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $331,684 | 6,880 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $362,774 | 6,889 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,131,397 | 22,875 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,099,300 | 22,624 | Shares | Defined | 2021-03-05 | |
| 2020-09-30 | $1,363,419 | 27,176 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,666,884 | 32,652 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,425,534 | 32,606 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||